NEW YORK (Reuters Health) – In patients with impaired renal function, the type of nonionic contrast agent used for coronary angiography seems to make little difference to the subsequent rate of contrast-induced nephrotoxicity, a Korean team has shown.
Dr. Tae-Jin Youn, at Seoul National University, and...